Cytokinetics Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

CYTK
Cytokinetics

Last Price:

$43.21

Seasonality Move:

9.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Cytokinetics Stock Forecast

Over the next 52 weeks, Cytokinetics has on average historically risen by 11.4% based on the past 20 years of stock performance.
Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
Is Cytokinetics Stock Undervalued?

The current Cytokinetics [CYTK] share price is $43.19. The Score for CYTK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
CYTK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

Over the next 52 weeks, Cytokinetics has on average historically risen by 11.4% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell

Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

cytokinetics.com

52-Week Data

52-Week High:

75.71

52-Week Low:

40.53

Prediction Charts

Market Cap:

5.1B

Price in USD:

43.19

Volume:

1.5M

Beta:

1.44

Technical Analysis

SMA50:

45.78

SMA100:

48.16

SMA200:

51.56

52-Wk Change:

-38.4%

Stock Predictions

Is Cytokinetics stock public?

Yes, Cytokinetics is a publicly traded company.
What is the Cytokinetics stock quote today?

The Cytokinetics stock price is 43.19 USD today.
How to buy Cytokinetics stock online?

You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-11	43.46	44.40	44.91	42.04
Mar-12	44.77	43.99	45.07	43.55
Mar-13	43.74	44.40	44.43	42.54
Mar-14	44.84	44.36	45.00	43.52
Mar-17	44.25	44.91	45.52	43.78
Mar-18	44.16	43.28	44.68	42.86
Mar-19	43.00	43.45	43.83	42.71
Mar-20	43.00	43.10	44.27	42.66
Mar-21	42.72	45.43	47.00	42.70
Mar-24	45.58	46.57	48.43	45.58
Mar-25	46.02	44.55	46.07	43.87
Mar-26	44.41	43.63	44.82	42.89
Mar-27	44.07	42.99	44.44	42.68
Mar-28	42.83	43.19	43.33	41.70

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.46 per share, and an increase next year of $0.81 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.